Longer term For longer protocols, review trends every 3-6 months with a clinician
Exclusion criteria included (a) clinical studies that had menopause hormone therapy as a treatment, (b) case reports, (c) in vitro studies or (d) animal studies, and (e) duplicate articles or off-topic articles
Each tablet contains: L-Glutathione 500 mg OTHER INGREDIENTS: Colloidal anhydrous silica, copovidone, talc, magnesium stearate, sucralose, orange flavouring (maltodextrin, acacia gum, ascorbic acid), isomalt, sorbitol, sodium saccharin
Principles and recent developments in chelation treatment of metal intoxication
Antibodies The following rabbit polyclonal antibodies were used: anti-GSTM2 (#ab125,102, Abcam, Cambridge, UK, 1:1000), anti-GSTM2 (#A13,496, ABclonal, Wuhan, China, 1:2000), anti-GAPDH (#CSB-PA00025A0Rb Flarebio Biotech LLC, College Park, MD, USA, 1:1000), anti-CIDEC (#D222114, Sangon Biotech, Shanghai, China, 1:1000), anti-CIDEC (#12287-1-AP, Proteintech, Rocky Hill, NJ, USA, 1:1000), anti-ADRP/perilipin2 (#15294-1-AP, Proteintech), anti-DGAT2 (#bs-12,998R, BIOSS, Beijing, China), anti-DGAT2 (#A13,891, ABclonal, Wuhan, China, 1:2000), anti-GPAT4 (#bs-15,587R, BIOSS), anti-SREBP1 (#14,088-1-AP, Proteintech), and anti-PCYT1A (#bs-11306R, BIOSS), anti-PCYT1A (#A5935, ABclonal, Wuhan, China, 1:1000)